Pharmaceutical Development Preclinical CRO Market, Global Outlook and Forecast 2022-2028

June 2022 | 69 pages | ID: P0140FA98457EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Pharmaceutical Development Preclinical CRO in Global, including the following market information:

Global Pharmaceutical Development Preclinical CRO Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Pharmaceutical Development Preclinical CRO market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Bioanalysis and DMPK Studies Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Pharmaceutical Development Preclinical CRO include Charles River, Wuxi AppTec, Labcorp, Eurofins Scientific, PPD, Inc., ICON Plc., Pharmaron, Inotiv and ChemPartner, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharmaceutical Development Preclinical CRO companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pharmaceutical Development Preclinical CRO Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Pharmaceutical Development Preclinical CRO Market Segment Percentages, by Type, 2021 (%)

• Bioanalysis and DMPK Studies
• Toxicology Testing
• Safety Pharmacology
• Others

Global Pharmaceutical Development Preclinical CRO Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Pharmaceutical Development Preclinical CRO Market Segment Percentages, by Application, 2021 (%)

• Small and Medium Pharmaceutical Company
• Large Pharmaceutical Company

Global Pharmaceutical Development Preclinical CRO Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Pharmaceutical Development Preclinical CRO Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Pharmaceutical Development Preclinical CRO revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Pharmaceutical Development Preclinical CRO revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Charles River
• Wuxi AppTec
• Labcorp
• Eurofins Scientific
• PPD, Inc.
• ICON Plc.
• Pharmaron
• Inotiv
• ChemPartner
• JOINN Lab
• EVOTEC
• Medicilon
• Crown Bioscience
• Champion Oncology

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Pharmaceutical Development Preclinical CRO Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Pharmaceutical Development Preclinical CRO Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PHARMACEUTICAL DEVELOPMENT PRECLINICAL CRO OVERALL MARKET SIZE

2.1 Global Pharmaceutical Development Preclinical CRO Market Size: 2021 VS 2028
2.2 Global Pharmaceutical Development Preclinical CRO Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Pharmaceutical Development Preclinical CRO Players in Global Market
3.2 Top Global Pharmaceutical Development Preclinical CRO Companies Ranked by Revenue
3.3 Global Pharmaceutical Development Preclinical CRO Revenue by Companies
3.4 Top 3 and Top 5 Pharmaceutical Development Preclinical CRO Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pharmaceutical Development Preclinical CRO Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmaceutical Development Preclinical CRO Players in Global Market
  3.6.1 List of Global Tier 1 Pharmaceutical Development Preclinical CRO Companies
  3.6.2 List of Global Tier 2 and Tier 3 Pharmaceutical Development Preclinical CRO Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Pharmaceutical Development Preclinical CRO Market Size Markets, 2021 & 2028
  4.1.2 Bioanalysis and DMPK Studies
  4.1.3 Toxicology Testing
  4.1.4 Safety Pharmacology
  4.1.5 Others
4.2 By Type - Global Pharmaceutical Development Preclinical CRO Revenue & Forecasts
  4.2.1 By Type - Global Pharmaceutical Development Preclinical CRO Revenue, 2017-2022
  4.2.2 By Type - Global Pharmaceutical Development Preclinical CRO Revenue, 2023-2028
  4.2.3 By Type - Global Pharmaceutical Development Preclinical CRO Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Pharmaceutical Development Preclinical CRO Market Size, 2021 & 2028
  5.1.2 Small and Medium Pharmaceutical Company
  5.1.3 Large Pharmaceutical Company
5.2 By Application - Global Pharmaceutical Development Preclinical CRO Revenue & Forecasts
  5.2.1 By Application - Global Pharmaceutical Development Preclinical CRO Revenue, 2017-2022
  5.2.2 By Application - Global Pharmaceutical Development Preclinical CRO Revenue, 2023-2028
  5.2.3 By Application - Global Pharmaceutical Development Preclinical CRO Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Pharmaceutical Development Preclinical CRO Market Size, 2021 & 2028
6.2 By Region - Global Pharmaceutical Development Preclinical CRO Revenue & Forecasts
  6.2.1 By Region - Global Pharmaceutical Development Preclinical CRO Revenue, 2017-2022
  6.2.2 By Region - Global Pharmaceutical Development Preclinical CRO Revenue, 2023-2028
  6.2.3 By Region - Global Pharmaceutical Development Preclinical CRO Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Pharmaceutical Development Preclinical CRO Revenue, 2017-2028
  6.3.2 US Pharmaceutical Development Preclinical CRO Market Size, 2017-2028
  6.3.3 Canada Pharmaceutical Development Preclinical CRO Market Size, 2017-2028
  6.3.4 Mexico Pharmaceutical Development Preclinical CRO Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Pharmaceutical Development Preclinical CRO Revenue, 2017-2028
  6.4.2 Germany Pharmaceutical Development Preclinical CRO Market Size, 2017-2028
  6.4.3 France Pharmaceutical Development Preclinical CRO Market Size, 2017-2028
  6.4.4 U.K. Pharmaceutical Development Preclinical CRO Market Size, 2017-2028
  6.4.5 Italy Pharmaceutical Development Preclinical CRO Market Size, 2017-2028
  6.4.6 Russia Pharmaceutical Development Preclinical CRO Market Size, 2017-2028
  6.4.7 Nordic Countries Pharmaceutical Development Preclinical CRO Market Size, 2017-2028
  6.4.8 Benelux Pharmaceutical Development Preclinical CRO Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Pharmaceutical Development Preclinical CRO Revenue, 2017-2028
  6.5.2 China Pharmaceutical Development Preclinical CRO Market Size, 2017-2028
  6.5.3 Japan Pharmaceutical Development Preclinical CRO Market Size, 2017-2028
  6.5.4 South Korea Pharmaceutical Development Preclinical CRO Market Size, 2017-2028
  6.5.5 Southeast Asia Pharmaceutical Development Preclinical CRO Market Size, 2017-2028
  6.5.6 India Pharmaceutical Development Preclinical CRO Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Pharmaceutical Development Preclinical CRO Revenue, 2017-2028
  6.6.2 Brazil Pharmaceutical Development Preclinical CRO Market Size, 2017-2028
  6.6.3 Argentina Pharmaceutical Development Preclinical CRO Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Pharmaceutical Development Preclinical CRO Revenue, 2017-2028
  6.7.2 Turkey Pharmaceutical Development Preclinical CRO Market Size, 2017-2028
  6.7.3 Israel Pharmaceutical Development Preclinical CRO Market Size, 2017-2028
  6.7.4 Saudi Arabia Pharmaceutical Development Preclinical CRO Market Size, 2017-2028
  6.7.5 UAE Pharmaceutical Development Preclinical CRO Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Charles River
  7.1.1 Charles River Corporate Summary
  7.1.2 Charles River Business Overview
  7.1.3 Charles River Pharmaceutical Development Preclinical CRO Major Product Offerings
  7.1.4 Charles River Pharmaceutical Development Preclinical CRO Revenue in Global Market (2017-2022)
  7.1.5 Charles River Key News
7.2 Wuxi AppTec
  7.2.1 Wuxi AppTec Corporate Summary
  7.2.2 Wuxi AppTec Business Overview
  7.2.3 Wuxi AppTec Pharmaceutical Development Preclinical CRO Major Product Offerings
  7.2.4 Wuxi AppTec Pharmaceutical Development Preclinical CRO Revenue in Global Market (2017-2022)
  7.2.5 Wuxi AppTec Key News
7.3 Labcorp
  7.3.1 Labcorp Corporate Summary
  7.3.2 Labcorp Business Overview
  7.3.3 Labcorp Pharmaceutical Development Preclinical CRO Major Product Offerings
  7.3.4 Labcorp Pharmaceutical Development Preclinical CRO Revenue in Global Market (2017-2022)
  7.3.5 Labcorp Key News
7.4 Eurofins Scientific
  7.4.1 Eurofins Scientific Corporate Summary
  7.4.2 Eurofins Scientific Business Overview
  7.4.3 Eurofins Scientific Pharmaceutical Development Preclinical CRO Major Product Offerings
  7.4.4 Eurofins Scientific Pharmaceutical Development Preclinical CRO Revenue in Global Market (2017-2022)
  7.4.5 Eurofins Scientific Key News
7.5 PPD, Inc.
  7.5.1 PPD, Inc. Corporate Summary
  7.5.2 PPD, Inc. Business Overview
  7.5.3 PPD, Inc. Pharmaceutical Development Preclinical CRO Major Product Offerings
  7.5.4 PPD, Inc. Pharmaceutical Development Preclinical CRO Revenue in Global Market (2017-2022)
  7.5.5 PPD, Inc. Key News
7.6 ICON Plc.
  7.6.1 ICON Plc. Corporate Summary
  7.6.2 ICON Plc. Business Overview
  7.6.3 ICON Plc. Pharmaceutical Development Preclinical CRO Major Product Offerings
  7.6.4 ICON Plc. Pharmaceutical Development Preclinical CRO Revenue in Global Market (2017-2022)
  7.6.5 ICON Plc. Key News
7.7 Pharmaron
  7.7.1 Pharmaron Corporate Summary
  7.7.2 Pharmaron Business Overview
  7.7.3 Pharmaron Pharmaceutical Development Preclinical CRO Major Product Offerings
  7.7.4 Pharmaron Pharmaceutical Development Preclinical CRO Revenue in Global Market (2017-2022)
  7.7.5 Pharmaron Key News
7.8 Inotiv
  7.8.1 Inotiv Corporate Summary
  7.8.2 Inotiv Business Overview
  7.8.3 Inotiv Pharmaceutical Development Preclinical CRO Major Product Offerings
  7.8.4 Inotiv Pharmaceutical Development Preclinical CRO Revenue in Global Market (2017-2022)
  7.8.5 Inotiv Key News
7.9 ChemPartner
  7.9.1 ChemPartner Corporate Summary
  7.9.2 ChemPartner Business Overview
  7.9.3 ChemPartner Pharmaceutical Development Preclinical CRO Major Product Offerings
  7.9.4 ChemPartner Pharmaceutical Development Preclinical CRO Revenue in Global Market (2017-2022)
  7.9.5 ChemPartner Key News
7.10 JOINN Lab
  7.10.1 JOINN Lab Corporate Summary
  7.10.2 JOINN Lab Business Overview
  7.10.3 JOINN Lab Pharmaceutical Development Preclinical CRO Major Product Offerings
  7.10.4 JOINN Lab Pharmaceutical Development Preclinical CRO Revenue in Global Market (2017-2022)
  7.10.5 JOINN Lab Key News
7.11 EVOTEC
  7.11.1 EVOTEC Corporate Summary
  7.11.2 EVOTEC Business Overview
  7.11.3 EVOTEC Pharmaceutical Development Preclinical CRO Major Product Offerings
  7.11.4 EVOTEC Pharmaceutical Development Preclinical CRO Revenue in Global Market (2017-2022)
  7.11.5 EVOTEC Key News
7.12 Medicilon
  7.12.1 Medicilon Corporate Summary
  7.12.2 Medicilon Business Overview
  7.12.3 Medicilon Pharmaceutical Development Preclinical CRO Major Product Offerings
  7.12.4 Medicilon Pharmaceutical Development Preclinical CRO Revenue in Global Market (2017-2022)
  7.12.5 Medicilon Key News
7.13 Crown Bioscience
  7.13.1 Crown Bioscience Corporate Summary
  7.13.2 Crown Bioscience Business Overview
  7.13.3 Crown Bioscience Pharmaceutical Development Preclinical CRO Major Product Offerings
  7.13.4 Crown Bioscience Pharmaceutical Development Preclinical CRO Revenue in Global Market (2017-2022)
  7.13.5 Crown Bioscience Key News
7.14 Champion Oncology
  7.14.1 Champion Oncology Corporate Summary
  7.14.2 Champion Oncology Business Overview
  7.14.3 Champion Oncology Pharmaceutical Development Preclinical CRO Major Product Offerings
  7.14.4 Champion Oncology Pharmaceutical Development Preclinical CRO Revenue in Global Market (2017-2022)
  7.14.5 Champion Oncology Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Pharmaceutical Development Preclinical CRO Market Opportunities & Trends in Global Market
Table 2. Pharmaceutical Development Preclinical CRO Market Drivers in Global Market
Table 3. Pharmaceutical Development Preclinical CRO Market Restraints in Global Market
Table 4. Key Players of Pharmaceutical Development Preclinical CRO in Global Market
Table 5. Top Pharmaceutical Development Preclinical CRO Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pharmaceutical Development Preclinical CRO Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pharmaceutical Development Preclinical CRO Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pharmaceutical Development Preclinical CRO Product Type
Table 9. List of Global Tier 1 Pharmaceutical Development Preclinical CRO Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharmaceutical Development Preclinical CRO Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pharmaceutical Development Preclinical CRO Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pharmaceutical Development Preclinical CRO Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pharmaceutical Development Preclinical CRO Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pharmaceutical Development Preclinical CRO Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pharmaceutical Development Preclinical CRO Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pharmaceutical Development Preclinical CRO Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2023-2028
Table 30. Charles River Corporate Summary
Table 31. Charles River Pharmaceutical Development Preclinical CRO Product Offerings
Table 32. Charles River Pharmaceutical Development Preclinical CRO Revenue (US$, Mn), (2017-2022)
Table 33. Wuxi AppTec Corporate Summary
Table 34. Wuxi AppTec Pharmaceutical Development Preclinical CRO Product Offerings
Table 35. Wuxi AppTec Pharmaceutical Development Preclinical CRO Revenue (US$, Mn), (2017-2022)
Table 36. Labcorp Corporate Summary
Table 37. Labcorp Pharmaceutical Development Preclinical CRO Product Offerings
Table 38. Labcorp Pharmaceutical Development Preclinical CRO Revenue (US$, Mn), (2017-2022)
Table 39. Eurofins Scientific Corporate Summary
Table 40. Eurofins Scientific Pharmaceutical Development Preclinical CRO Product Offerings
Table 41. Eurofins Scientific Pharmaceutical Development Preclinical CRO Revenue (US$, Mn), (2017-2022)
Table 42. PPD, Inc. Corporate Summary
Table 43. PPD, Inc. Pharmaceutical Development Preclinical CRO Product Offerings
Table 44. PPD, Inc. Pharmaceutical Development Preclinical CRO Revenue (US$, Mn), (2017-2022)
Table 45. ICON Plc. Corporate Summary
Table 46. ICON Plc. Pharmaceutical Development Preclinical CRO Product Offerings
Table 47. ICON Plc. Pharmaceutical Development Preclinical CRO Revenue (US$, Mn), (2017-2022)
Table 48. Pharmaron Corporate Summary
Table 49. Pharmaron Pharmaceutical Development Preclinical CRO Product Offerings
Table 50. Pharmaron Pharmaceutical Development Preclinical CRO Revenue (US$, Mn), (2017-2022)
Table 51. Inotiv Corporate Summary
Table 52. Inotiv Pharmaceutical Development Preclinical CRO Product Offerings
Table 53. Inotiv Pharmaceutical Development Preclinical CRO Revenue (US$, Mn), (2017-2022)
Table 54. ChemPartner Corporate Summary
Table 55. ChemPartner Pharmaceutical Development Preclinical CRO Product Offerings
Table 56. ChemPartner Pharmaceutical Development Preclinical CRO Revenue (US$, Mn), (2017-2022)
Table 57. JOINN Lab Corporate Summary
Table 58. JOINN Lab Pharmaceutical Development Preclinical CRO Product Offerings
Table 59. JOINN Lab Pharmaceutical Development Preclinical CRO Revenue (US$, Mn), (2017-2022)
Table 60. EVOTEC Corporate Summary
Table 61. EVOTEC Pharmaceutical Development Preclinical CRO Product Offerings
Table 62. EVOTEC Pharmaceutical Development Preclinical CRO Revenue (US$, Mn), (2017-2022)
Table 63. Medicilon Corporate Summary
Table 64. Medicilon Pharmaceutical Development Preclinical CRO Product Offerings
Table 65. Medicilon Pharmaceutical Development Preclinical CRO Revenue (US$, Mn), (2017-2022)
Table 66. Crown Bioscience Corporate Summary
Table 67. Crown Bioscience Pharmaceutical Development Preclinical CRO Product Offerings
Table 68. Crown Bioscience Pharmaceutical Development Preclinical CRO Revenue (US$, Mn), (2017-2022)
Table 69. Champion Oncology Corporate Summary
Table 70. Champion Oncology Pharmaceutical Development Preclinical CRO Product Offerings
Table 71. Champion Oncology Pharmaceutical Development Preclinical CRO Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Pharmaceutical Development Preclinical CRO Segment by Type in 2021
Figure 2. Pharmaceutical Development Preclinical CRO Segment by Application in 2021
Figure 3. Global Pharmaceutical Development Preclinical CRO Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pharmaceutical Development Preclinical CRO Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pharmaceutical Development Preclinical CRO Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pharmaceutical Development Preclinical CRO Revenue in 2021
Figure 8. By Type - Global Pharmaceutical Development Preclinical CRO Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pharmaceutical Development Preclinical CRO Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pharmaceutical Development Preclinical CRO Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pharmaceutical Development Preclinical CRO Revenue Market Share, 2017-2028
Figure 12. US Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pharmaceutical Development Preclinical CRO Revenue Market Share, 2017-2028
Figure 16. Germany Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2017-2028
Figure 17. France Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pharmaceutical Development Preclinical CRO Revenue Market Share, 2017-2028
Figure 24. China Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2017-2028
Figure 28. India Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pharmaceutical Development Preclinical CRO Revenue Market Share, 2017-2028
Figure 30. Brazil Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pharmaceutical Development Preclinical CRO Revenue Market Share, 2017-2028
Figure 33. Turkey Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pharmaceutical Development Preclinical CRO Revenue, (US$, Mn), 2017-2028
Figure 37. Charles River Pharmaceutical Development Preclinical CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Wuxi AppTec Pharmaceutical Development Preclinical CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Labcorp Pharmaceutical Development Preclinical CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Eurofins Scientific Pharmaceutical Development Preclinical CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. PPD, Inc. Pharmaceutical Development Preclinical CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. ICON Plc. Pharmaceutical Development Preclinical CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Pharmaron Pharmaceutical Development Preclinical CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Inotiv Pharmaceutical Development Preclinical CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. ChemPartner Pharmaceutical Development Preclinical CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. JOINN Lab Pharmaceutical Development Preclinical CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. EVOTEC Pharmaceutical Development Preclinical CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Medicilon Pharmaceutical Development Preclinical CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Crown Bioscience Pharmaceutical Development Preclinical CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Champion Oncology Pharmaceutical Development Preclinical CRO Revenue Year Over Year Growth (US$, Mn) & (2017-2022)